Amicus Therapeutics Inc (FOLD)
9.79
-0.05
(-0.51%)
USD |
NASDAQ |
Dec 24, 16:00
Amicus Therapeutics Cash from Investing (Quarterly): 34.27M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | -0.009M |
| Immuneering Corp | -5.415M |
| Alnylam Pharmaceuticals Inc | -30.25M |
| Insmed Inc | -1.003B |
| Ionis Pharmaceuticals Inc | -340.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.97M |
| Cash from Financing (Quarterly) | 18.19M |
| Free Cash Flow | -31.51M |
| Free Cash Flow Per Share (Quarterly) | -0.0766 |
| Free Cash Flow to Equity (Quarterly) | -23.88M |
| Free Cash Flow to Firm (Quarterly) | -34.84M |
| Free Cash Flow Yield | -1.06% |